Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis

Detalles Bibliográficos
Autor principal: Yoon, Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667369/
https://www.ncbi.nlm.nih.gov/pubmed/31352773
http://dx.doi.org/10.5217/ir.2019.00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667369/
https://www.ncbi.nlm.nih.gov/pubmed/31352773
http://dx.doi.org/10.5217/ir.2019.00070

Ejemplares similares